Fund Houses Recommendations: bpcl, iocl, hdfcbank, techmahindra, abfrl, hpcl, ipcalab

આજે Entero Healthcareનો આઇપીઓ લિસ્ટેડ થશે

અમદાવાદ, 16 ફેબ્રુઆરીઃ આજે એન્ટેરો હેલ્થકેરનો આઇપીઓ લિસ્ટેડ થશે. તે ઉપરાંત વિવિધ અગ્રણી બ્રોકરેજ હાઉસ તેમજ ફંડ હાઉસ તરફથી ખરીદી/ વેચાણ/ હોલ્ડ કરવા માટે સલાહ આપવામાં આવી છે. જે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

Jefferies on BPCL: Upgrades to Buy on Company, raise target price at Rs 890 (Positive)

Jefferies on IOCL: Maintain Hold on Company, raise target price at Rs 215 (Positive)

MS on HDFC Bank: Maintain Overweight on Bank, target price at Rs 2110 (Positive)

CLSA ON IT Sector: Gives an outperform call on Infosys and Tech Mah (Positive)

Citi on Crompton: Maintain Buy on Company, raise target price at Rs 350 (Positive)

Citi on NMDC: Maintain Sell on Company, raise target price at Rs 215 (Neutral)

Citi on ABFRL: Maintain Sell on Company, target price at Rs 220 (Neutral)

Nuvama on ABFRL: Maintain Neutral on Company, raise target price at Rs 275 (Neutral)

Macquarie on United Spirits: Maintain Underperform on Company, target price at Rs 910 (Neutral)

MS on SBI Cards: Maintain Equal weight on Company, target price at Rs 750 (Neutral)

Jefferies on HPCL: Maintain Underperform on Company, raise target price at Rs 550 (Neutral)

HSBC on IPCA Labs: Maintain Hold on Company, target price at Rs 1125 (Neutral)

MS on Crompton: Maintain Equal weight on Company, target price at Rs 281 (Neutral)

Nomura on Eureka: Maintain Neutral on Company, target price at Rs 568 (Neutral)

CLSA on Sun TV: Downgrades to Outperform on Company, raise target price at Rs 675 (Neutral)

Nuvama on Gujarat Gas: Maintain Buy on Company, target price at Rs 676 (Neutral)

Emkay on Gujarat Gas: Downgrades to Sell on Company, target price at Rs 440 (Negative)

CLSA on Gujarat Gas: Maintain Sell on Company, cut target price at Rs 360 (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)